Publications by authors named "David Adelberg"

Claim this Profile
L
Lenvatinib Plus Pembrolizumab Versus Standard of Care for Previously Treated Metastatic Colorectal Cancer: Final Analysis of the Randomized, Open-Label, Phase III LEAP-017 Study.
Akihito Kawazoe, Rui-Hua Xu, Pilar García-Alfonso, Maria Passhak, Hao-Wei Teng, David Adelberg

J Clin Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olaparib with or without bevacizumab versus bevacizumab plus a fluoropyrimidine as maintenance therapy in advanced colorectal cancer: The randomized phase 3 LYNK-003 study.
Atsuo Takashima, Pilar García-Alfonso, Raimundo Manneh, Ali Ayberk Beşen, Yong Sang Hong, David Adelberg

Eur J Cancer· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab Plus Binimetinib With or Without Chemotherapy for MSS/pMMR Metastatic Colorectal Cancer: Outcomes From KEYNOTE-651 Cohorts A, C, and E.
Eric X Chen, Petr Kavan, Mustapha Tehfe, Jeremy S Kortmansky, Michael B Sawyer, David Adelberg

Clin Colorectal Cancer· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab Plus mFOLFOX7 or FOLFIRI for Microsatellite Stable/Mismatch Repair-Proficient Metastatic Colorectal Cancer: KEYNOTE-651 Cohorts B and D.
Richard Kim, Mustapha Tehfe, Petr Kavan, Jorge Chaves, Jeremy S Kortmansky, David Adelberg

Clin Colorectal Cancer· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KEYNOTE-859: a Phase III study of pembrolizumab plus chemotherapy in gastric/gastroesophageal junction adenocarcinoma.
Josep Tabernero, Yung-Jue Bang, Eric Van Cutsem, Charles S Fuchs, Yelena Yuriy Janjigian, David Adelberg

Future Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Pembrolizumab Therapy for the Treatment of Microsatellite Instability-High Gastric or Gastroesophageal Junction Cancer Among Patients in the KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Clinical Trials.
Joseph Chao, Charles S Fuchs, Kohei Shitara, Josep Tabernero, Kei Muro, David Adelberg

JAMA Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KEYNOTE-585: Phase III study of perioperative chemotherapy with or without pembrolizumab for gastric cancer.
Yung-Jue Bang, Eric Van Cutsem, Charles S Fuchs, Atsushi Ohtsu, Josep Tabernero, David Adelberg

Future Oncol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study of TRC105 anti-endoglin (CD105) antibody in metastatic castration-resistant prostate cancer.
Fatima H Karzai, Andrea B Apolo, Liang Cao, Ravi A Madan, David E Adelberg

BJU Int· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II clinical trial of cediranib in patients with metastatic castration-resistant prostate cancer.
William L Dahut, Ravi A Madan, Joyson J Karakunnel, David Adelberg, James L Gulley

BJU Int· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A SNP in CYP2C8 is not associated with the development of bisphosphonate-related osteonecrosis of the jaw in men with castrate-resistant prostate cancer.
Bevin C English, Caitlin E Baum, David E Adelberg, Tristan M Sissung, Paul G Kluetz

Ther Clin Risk Manag· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emergencies related to cancer chemotherapy and hematopoietic stem cell transplantation.
David E Adelberg, Michael R Bishop

Emerg Med Clin North Am· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis